CTOs on the Move

Verana Health

www.veranahealth.com

 
Verana Health is a healthcare technology and analytics company entrusted by key medical associations to manage multi-specialty, real-world data at every stage of the analytics process—from entry to evidence. Anchored in ophthalmology, neurology, and urology, the Company acts as a linchpin in the healthcare data ecosystem, normalizing data and enhancing its clinical richness and quality to empower physicians and accelerate research for patients. By curating and applying advanced analytics to real-world clinical data, Verana Health helps life sciences partners enhance evidence generation, reinvent observational and prospective research, and drive innovations in specific disease areas.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Kirk Fjeldheim
Chief Information Security Officer Profile
Jung Kim
Director, Security and Compliance Profile

Funding

Verana Health raised $30M on 07/31/2018
Verana Health raised $100M on 02/05/2020
Verana Health raised $150M on 01/14/2022

Similar Companies

Quilleer and Blake Advertising

Quilleer and Blake Advertising is a Buffalo, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wilderness Adventure At Eagle

Wilderness Adventure At Eagle is a New Castle, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TherOx

TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.

IBC USA Conferences

IBC USA Conferences is a Westborough, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifesharing Community Organ

Lifesharing Community Organ is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.